5 ESSENTIAL ELEMENTS FOR ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)

In Phase A, members will obtain various doses and schedules of oral ABBV-744 pill to detect Safe and sound dosing routine. Further participants will be enrolled at the determined monotherapy dosign regimen. In Phase B, individuals will acquire oral ruxolitinib and ABBV-744 is going to be provided as "add-on" therapy. In Section C, individuals will